NCT05939453Active, not recruiting
Impact of Bright Light Therapy on Prader-Willi Syndrome
A Randomized, Double-Blind, Controlled Trial of Bright Light Therapy on All-Cause Excessive Daytime Sleepiness in Prader-Willi Syndrome
Source: ClinicalTrials.gov · Last updated 6 Oct 2026
Brief summary (registry, in English)
This is a placebo controlled clinical trial to assess the utility of light therapy as a sufficient treatment for excessive daytime sleepiness in patients with Prader-Willi Syndrome
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- First submitted
- 12 Dec 2022
- Start date
- 1 Oct 2023
- Primary completion date
- 30 Sept 2026
- Lead sponsor
- Maimonides Medical Center
- NCT number
- NCT05939453
What you commit to
- Study type: Interventional
- Planned participants: 50
- From 1 Oct 2023 to the primary completion date, 30 Sept 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- A history of previous treatment with LT
Other illness
- Subjects with an eye condition that could be negatively affected by bright light such as patients with a history of retinal damage or patients needing photosensitizing medications
Other
- Patients presenting with active psychosis or mania
Who the study is looking for
- Diagnosis of PWS confirmed by genetic testing
- Score of 12 or above on the Epworth Sleepiness Scale (ESS).
Age in the registry: 6 years to 88 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Maimonides Medical Center Coordinator of this site? Confirm its status | Brooklyn | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.